May 6, 2015 — The Spectranetics Corporation announced it is accelerating investments in the Stellarex drug-coated ...
Peripheral Artery Disease (PAD)
This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.
April 29, 2015 — A key trial evaluating the Boston Scientific Eluvia drug-eluting vascular stent system met its primary ...
In 2015, the FDA approved the first two drug-coated balloons for the U.S. market to treat peripheral artery disease in ...
March 9, 2015 — Boston Scientific Corp. announced the settlement of the breach of merger agreement lawsuit brought by ...
February 23, 2015 – Biotronik announced the presentation of data from the iliac arm of the BIOFLEX-I clinical trial at ...
March 6, 2015 — Merck announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist ...
March 2, 2015 — Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global ...
February 26, 2015 — Approximately 8 to 12 million people in the United States alone are suffering from peripheral ...
February 25, 2015 — CBSET, a not-for-profit preclinical research institute, announced that its scientists have defined ...
February 23, 2015 — Medtronic announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a ...
Drug-eluting balloons (DEBs), also referred to as drug-coated balloons (DCBs), have been one of the long-awaited new ...
February 9, 2015 — Ensuring that patients with peripheral arterial disease (PAD) get tested and treated with minimally ...
February 6, 2015 — United States hospitals began using a new medical device from Medtronic plc called the In.Pact ...
January 30, 2015 — ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology ...
January 16, 2015 — Non-contrast enhanced MR angiography (MRA) techniques have attracted interest in the medical ...